Blockchain Registration Transaction Record

GeoVax Applauds New Global Mpox Vaccine Stockpile; GEO-MVA Ready for Phase 3

GeoVax welcomes global mpox vaccine stockpile, highlighting GEO-MVA's readiness for Phase 3 to support diversified supply. Learn about the initiative's impact.

The establishment of a global mpox vaccine stockpile marks a critical shift from reactive outbreak control to proactive preparedness, ensuring that vaccines are available equitably and swiftly during future mpox emergencies. For the public, this means reduced risk of severe outbreaks and better protection for vulnerable populations worldwide. For GeoVax, it underscores the importance of diversifying vaccine supply and manufacturing capacity, which is essential for meeting global demand and enhancing biosecurity. The company's progress with GEO-MVA could contribute to a more resilient supply chain, ultimately saving lives and preventing widespread disruption.